Evidence map›Paper›PMID 39738767›Full record

ArticleScientific reports2024

NF2 can mediate the expression of CAMK2A in a tissue specific manner.

Zhaoying Lei, Huajian Cai, Qingfeng Yan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhaoying Lei *College of Life Sciences, Zhejiang University, Zhejiang, 310058, China.
Huajian Cai *College of Life Sciences, Zhejiang University, Zhejiang, 310058, China.
Qingfeng YanCollege of Life Sciences, Zhejiang University, Zhejiang, 310058, China. qfyan@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningioma is the most prevalent primary intracranial tumor, with approximately half of patients harboring NF2 alteration. The rationale behind the presence of NF2 alteration in meningiomas and its absence in non-nerve system tumors remains elusive. Therefore, meningiomas and several non-nerve system tumor types were analyzed using KEGG analysis and CRISPR/Cas 9 technology to determine the role of NF2 in regulating tissue specificity. Moreover, the different regulatory patterns of Ca

Indexed as

Calcium-Calmodulin-Dependent Protein Kinase Type 2Gene Expression Regulation, NeoplasticCalciumHumansMeningeal NeoplasmsMeningiomaNeurofibromin 2Organ SpecificityCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2CAMK2A protein, humanNeurofibromin 2CAMK2AMeningiomasNF2Tissue-specificityTumor

Identifiers

PMID39738767
PMCPMC11685432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.